Timing of Antithrombotic Secondary Prevention in Patients with Intracranial Hemorrhage after Stroke Thrombolysis and Thrombectomy

Author:

Reale Giuseppe12,Caliandro Pietro3ORCID,Moreira Tiago T. P.45,Almqvist Håkan56,Giovannini Silvia7ORCID,Grannas David8,Kotopouli Maria Ioanna8,Laurienzo Andrea9,Löfberg Harald10,Moci Marco2,Sköldblom Sebastian11,Valente Iacopo12,Zauli Aurelia2,Holmin Staffan513ORCID,Mazya Michael V.45ORCID

Affiliation:

1. UOC Neuroriabilitazione ad Alta Intensità (Cod. 75), Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy

2. Department of Neurosciences, Università Cattolica del Sacro Cuore, 00168 Rome, Italy

3. UOC Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy

4. Department of Neurology, Karolinska University Hospital, 17177 Stockholm, Sweden

5. Department of Clinical Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden

6. Department of Radiology, Capio St Göran’s Hospital, 11219 Stockholm, Sweden

7. UOC Riabilitazione 2, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy

8. Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, 17177 Stockholm, Sweden

9. P.O. A. Cardarelli S.C. Neurologia-Stroke Unit, 86100 Campobasso, Italy

10. Department of Internal Medicine, Nyköping Hospital, 61139 Nyköping, Sweden

11. Division of Oncology, Karolinska University Hospital, 17177 Stockholm, Sweden

12. UOC Diagnostica Per Immagini, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy

13. Department of Neuroradiology, Karolinska University Hospital, 17177 Stockholm, Sweden

Abstract

In patients with acute ischemic stroke, hemorrhagic transformation (HT) of infarcted tissue frequently occurs after reperfusion treatment. We aimed to assess whether HT and its severity influences the start of secondary prevention therapy and increases the risk of stroke recurrence. In this retrospective dual-center study, we recruited ischemic stroke patients treated with thrombolysis, thrombectomy or both. Our primary outcome was the time between revascularization and the start of any secondary prevention therapy. The secondary outcome was ischemic stroke recurrence within three months. We compared patients with vs. without HT and no (n = 653), minor (n = 158) and major (n = 51) HT patients using propensity score matching. The delay in the start of antithrombotics or anticoagulants was median 24 h in no HT, 26 h in minor HT and 39 h in major HT. No and minor HT patients had similar rates of any stroke recurrence (3.4% (all ischemic) vs. 2.5% (1.6% ischemic plus 0.9% hemorrhagic)). Major HT patients had a higher stroke recurrence at 7.8% (3.9% ischemic, 3.9% hemorrhagic), but this difference did not reach significance. A total of 22% of major HT patients did not start any antithrombotic treatment during the three-month follow-up. In conclusion, the presence of HT influences the timing of secondary prevention in ischemic stroke patients undergoing reperfusion treatments. Minor HT did not delay the start of antithrombotics or anticoagulants compared to no HT, with no significant difference in safety outcomes. Major HT patients remain a clinical challenge with both a delayed or lacking start of treatment. In this group, we did not see a higher rate of ischemic recurrence; however, this may have been censored by elevated early mortality. While not reaching statistical significance, hemorrhagic recurrence was somewhat more common in this group, warranting further study using larger datasets.

Funder

Söderberg Foundations och MedTechLabs

Region Stockholm

Swedish Stroke Association

Publisher

MDPI AG

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3